| Property Name | Property Value | Unit | Raw Value | Raw Unit | Reference |
|---|---|---|---|---|---|
| Boiling Point | 707.2 | ℃ | 707.2 | ℃ | MSDS |
| Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Factor | Reference |
|---|---|---|---|---|---|---|---|
| Bioavailability | 79.0 | % | 79 | % | PO, oral; | DRUGBANK | |
| T Max | 1.0 | h | 1(0.5-3) | h | PO, oral; | DRUGBANK | T Max | 0.50 | h | 0.5 | h | PO, oral; food; | food ↓ ; | DRUGBANK |
| Metabolic | 10.0 | % | <10 | % | DRUGBANK | ||
| Clearance | 9.4 | L/h | ~9.42 | L/h | apparent clearance; rheumatoid arthritis; patients; | DRUGBANK | |
| Volume of Distribution | 76.0 | L | 76.0 | L | Average volume of distribution; intravenous infusion, IV in drop; | DRUGBANK | |
| Half-life | 12.5 | h | ~12.5 | h | rheumatoid arthritis; patients; | DRUGBANK | |
| Protein Binding | 50.0 | % | ~50 | % | plasma proteins; | DRUGBANK |
| Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Brand Name | Component | Reference |
|---|---|---|---|---|---|---|---|---|
| Max dose for adults | 2.0 | mg/day | 2 | mg/day | PO, oral | Olumiant | baricitinib | PDR |
| Max dose for geriatric | 2.0 | mg/day | 2 | mg/day | PO, oral | Olumiant | baricitinib | PDR |